🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of this study is to evaluate the safety of zanubrutin...
Status
Completed
Location
Rocky Mountain Cancer Centers (Williams) Usor
Start Date
2019-10-15
Trial ID
NCT04116437
Treatments Being Tested
Within this exploratory multicohort phase II trial, SAKK aims to evaluate a...
Status
Active Not Recruiting
Location
Ospedale Papa Giovanni XXIII
Start Date
2021-06-25
Trial ID
NCT04604067
Treatments Being Tested
The goal of this clinical trial is to study the addition of Acalabrutinib t...
Status
Recruiting
Location
Saarland University Medical Center
Start Date
2023-06-07
Trial ID
NCT05820841
Treatments Being Tested
The goal of this study is to test mosunetuzumab given alone or in combinati...
Status
Recruiting
Location
Brigham & Women's Hospital
Start Date
2025-11-24
Trial ID
NCT07052695
Treatments Being Tested
This study is to determine the response to acalabrutinib in patients with c...
Status
Completed
Location
Research Site
Start Date
2015-01-12
Trial ID
NCT02337829
Treatments Being Tested
This phase II trial compares three chemotherapy regimens consisting of bend...
Status
Active Not Recruiting
Location
Anchorage Associates in Radiation Medicine
Start Date
2019-12-13
Trial ID
NCT04115631
Treatments Being Tested
This is a study for participants with a type of blood cancer called mantle ...
Status
Active Not Recruiting
Location
Alaska Oncology and Hematology, LLC
Start Date
2021-04-08
Trial ID
NCT04662255
Treatments Being Tested
This trial will study how safely the tazemetostat works with other therapie...
Status
Withdrawn
Location
California Cancer Associates For Research And Excellence, cCARE
Start Date
2021-12-22
Trial ID
NCT05205252
This phase II trial studies how well acalabrutinib and venetoclax with or w...
Status
Recruiting
Location
M D Anderson Cancer Center
Start Date
2020-07-29
Trial ID
NCT04169737
Treatments Being Tested
Chronic lymphocytic leukemia (CLL) is the most common leukemia (cancer of b...
Status
Recruiting
Location
Arizona Oncology - Tucson - Rudasill /ID# 267552
Start Date
2024-08-05
Trial ID
NCT06428019
Treatments Being Tested